Market Cap (In USD)
31.96 Million
Revenue (In USD)
2.18 Million
Net Income (In USD)
-20.13 Million
Avg. Volume
352.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.7362-4.0
- PE
- -1.14
- EPS
- -0.87
- Beta Value
- 0.255
- ISIN
- US03476V1008
- CUSIP
- -
- CIK
- -
- Shares
- 32252277.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Andrew David William Newland ACA, Meng
- Employee Count
- -
- Website
- https://angleplc.com
- Ipo Date
- 2015-04-28
- Details
- ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
More Stocks
-
600999
-
SWX
-
BELLACASABella Casa Fashion & Retail Limited
BELLACASA
-
AURQFAurelius Minerals Inc.
AURQF
-
LQRLQR House Inc.
LQR
-
MINALINDMINAL INDUSTRIES LIMITED
MINALIND
-
AESB3AES Brasil Energia S.A.
AESB3
-
SOI